ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Neoplasm Metastasis
Endometrial Cancer
Non-Small-Cell Lung Carcinoma

Prostate Cancer trials near Seattle, WA, USA:

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

Seattle, Washington, United States and 92 other locations

This is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate...

Active, not recruiting
Metastatic Prostate Cancer
Drug: Apalutamide
Drug: Abiraterone acetate

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Seattle, Washington, United States and 11 other locations

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Seattle, Washington, United States and 7 other locations

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Tacoma, Washington, United States and 24 other locations

The study will be conducted in 4 parts and will commence with dose escalation of VIR-5500 as a monotherapy (Part 1), followed by combination escalati...

Enrolling
Hormone-refractory Prostate Cancer
Combination Product: Enzalutamide
Combination Product: Darolutamide

Phase 1

Vir Biotechnology

Seattle, Washington, United States and 8 other locations

The primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an...

Enrolling
Prostate Cancer
Drug: GnRH Antagonist
Drug: Xaluritamig

Phase 1

Amgen
Amgen

Seattle, Washington, United States and 7 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Seattle, Washington, United States and 42 other locations

This is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate...

Enrolling
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer (Adenocarcinoma)
Drug: ACE-232 tablets

Phase 1

Acerand Therapeutics (Hong Kong) Limited

Seattle, Washington, United States of America and 7 other locations

The goal of this clinical trial is to measure the toxicity and effectiveness of the following treatments for cFIR/cgUIR prostate cancer...

Enrolling
Prostate Cancer
Radiation: SBRT standard of care radiotherapy treatment
Drug: Relugolix 120 MG [Orgovyx]

Phase 2

Yale University
Yale University

Seattle, Washington, United States and 2 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Seattle, Washington, United States and 12 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems